Microarray analysis of genes associated with cell surface NIS protein levels in breast cancer

BMC Research Notes

Volumn 4, Issue , 2011, Pages

  Beyer, Sasha J ^a   Zhang, Xiaoli ^a   Jimenez, Rafael E ^b   Lee, Mei Ling T ^c   Richardson, Andrea L ^d   Huang, Kun ^a   Jhiang, Sissy M ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80053650424     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-4-397     Document Type: Article

References (42)

1. Transmission of radioiodine (I131) to infants through human maternal milk. Nurnberger CE, Lipscomb A, JAMA 1952 150 1398 1400
2. Transfer of radioiodine to milk and its inhibition. Mountford PJ, Coakley AJ, Fleet IR, Hamon M, Heap RB, Nature 1986 322 600 10.1038/322600a0 3018578 (Pubitemid 16011442)
3. The mammary gland iodide transporter is expressed during lactation and in breast cancer. Tazebay UH, Wapnir IL, Levy O, Dohan O, Zuckier LS, Zhao QH, Deng HF, Amenta PS, Fineberg S, Pestell RG, Carrasco N, Nat Med 2000 6 8 871 878 10.1038/78630 10932223 (Pubitemid 30644744)
4. Endogenous NIS Expression in Triple-Negative Breast Cancers. Renier C, Yao C, Goris M, Ghosh M, Nowles K, Gambhir S, Wapnir I, Ann Surg Oncol 2009 16 962 968 10.1245/s10434-008-0280-9 19184238
5. 99mTc-pertechnetate uptakes and expression of human sodium iodide symporter in breast tumor tissues. Moon DH, Lee SJ, Park KY, Park KK, Ahn SH, Pai MS, Chang H, Lee HK, Ahn IM, Nucl Med Biol 2001 28 829 834 10.1016/S0969-8051(01)00243-8 11578905 (Pubitemid 32900641)
6. The Na+/I- symporter mediates iodide uptake in breast cancer metastases and can be selectively down-regulated in the thyroid. Wapnir IL, Goris M, Yudd A, Dohan O, Adelman D, Nowels K, Carrasco N, Clin Cancer Res 2004 10 4294 4302 10.1158/1078-0432.CCR-04-0074 15240514 (Pubitemid 38878866)
7. PI3K activation up-regulates sodium iodide symporter expression yet impairs cell surface trafficking in breast cancer. Knostman K, McCubrey J, Morrison C, Zhang Z, Capen C, Jhiang S, BMC Cancer 2007 7 137 10.1186/1471-2407-7-137 17651485 (Pubitemid 47354239)
8. Expression of the Na+/I symporter in invasive ductal breast cancer. Rudnicka L, Sinczak A, Szybinski P, Huszno B, Stachura J, Folia Histochemica et Cytobiologica 2003 41 1 37 40 12705478 (Pubitemid 36215833)
9. The relationship between expression of the sodium/iodide symporter gene and the status of hormonal receptors in human breast cancer tissue. Oh HJ, Chung JK, Kang JH, Kang WJ, Noh DY, Park IA, Jeong JM, Lee DS, Lee MC, Cancer Res Treat 2005 37 4 247 250 10.4143/crt.2005.37.4.247 19956522
10. Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line. Kogai T, Schultz JJ, Johnson LS, Huang M, Brent GA, Proc Natl Acad Sci USA 2000 97 8519 8524 10.1073/pnas.140217197 10890895 (Pubitemid 30639705)
11. Differential Regulation of Sodium/Iodide Symporter Gene Expression by Nuclear Receptor Ligands in MCF-7 Breast Cancer Cells. Kogai T, Kanamoto Y, Li AI, Che LH, Ohashi E, Taki K, Chandraratna RA, Saito T, Brent GA, Endocrinology 2005 146 3059 3069 10.1210/en.2004-1334 15817668 (Pubitemid 41002815)
12. Systemic Retinoic Acid Treatment Induces Sodium/Iodide Symporter Expression and Radioiodide Uptake in Mouse Breast Cancer Models. Kogai T, Kanamoto Y, Che LH, Taki K, Moatamed F, Schultz JJ, Brent GA, Cancer Res 2004 64 415 422 10.1158/0008-5472.CAN-03-2285 14729653 (Pubitemid 38114126)
13. Dexamethasone Stimulation of Retinoic Acid-Induced Sodium Iodide Symporter Expression and Cytotoxicity of 131-I in Breast Cancer Cells. Unterholzner S, Willhauk MJ, Cengic N, Schutz M, Goke B, Morris JC, Spitzweg C, J Clin Endocrinol Metab 2006 91 69 78 10.1210/jc.2005-0779 16234306 (Pubitemid 43069120)
14. Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone. Willhauk MJ, Sharif-Samani B, Senekowitsch-Schmidtke R, Wunderlich N, Goke B, Morris JC, Spitzweg C, Breast Cancer Res Treat 2008 109 263 272 10.1007/s10549-007-9646-0 17636401 (Pubitemid 351644845)
15. Hydrocortisone and Purinergic Signaling Stimulate Sodium/Iodide Symporter (NIS)-Mediated Iodide Transport in Breast Cancer Cells. Dohan O, De la Vieja A, Carrasco N, Mol Endocrinol 2006 20 1121 1137 10.1210/me.2005-0376 16439463
16. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Edgar R, Domrachev M, Lash AE, Nucleic Acids Res 2002 30 1 207 210 10.1093/nar/30.1.207 11752295 (Pubitemid 34679544)
17. X chromosomal abnormalities in basal-like human breast cancer. Richardson AL, Wang ZC, De Nicolo A, Lu X, Cancer Cell 2006 9 2 121 32 10.1016/j.ccr.2006.01.013 16473279 (Pubitemid 43202662)
18. Identification of molecular apocrine breast tumours by microarray analysis. Farmer P, Bonnefoi H, Becette V, Tubiana-Hulin M, Fumoleau P, Larsimont D, Macgrogan G, Bergh J, Cameron D, Goldstein D, Duss S, Nicoulaz AL, Brisken C, Fiche M, Delorenzi M, Iggo R, Oncogene 2005 24 29 4660 71 10.1038/sj.onc.1208561 15897907 (Pubitemid 41032603)
19. Overexpression of E2F-5 correlates with a pathological basal phenotype and a worse clinical outcome. Umemura S, Shirane M, Takekoshi S, Kusakabe T, Itoh J, Egashira N, Tokuda Y, Mori K, Osamura YR, Br J Cancer 2009 100 5 764 71 10.1038/sj.bjc.6604900 19259095
20. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms. Sørlie T, Wang Y, Xiao C, Johnsen H, Naume B, Samaha RR, Børresen-Dale AL, BMC Genomics 2006 7 127 10.1186/1471-2164-7-127 16729877 (Pubitemid 44027496)
21. Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial. Bonnefoi H, Potti A, Delorenzi M, Mauriac L, Campone M, Tubiana-Hulin M, Petit T, Rouanet P, Jassem J, Blot E, Becette V, Farmer P, André S, Acharya CR, Mukherjee S, Cameron D, Bergh J, Nevins JR, Iggo RD, Lancet Oncol 2007 8 12 1044 5 10.1016/S1470-2045(07)70349-2 18054869 (Pubitemid 350182957)
22. Gene expression profiling of the tumor microenvironment during breast cancer progression. Ma XJ, Dahiya S, Richardson E, Erlander M, Sgroi DC, Breast Cancer Res 2009 11 7 10.1186/bcr2222 19187537
23. Predicting features of breast cancer with gene expression patterns. Lu X, Lu X, Wang ZC, Iglehart JD, Zhang X, Richardson AL, Breast Cancer Res Treat 2008 108 2 191 201 10.1007/s10549-007-9596-6 18297396 (Pubitemid 351311362)
24. Do cell surface trafficking impairments account for variable cell surface sodium iodide symporter levels in breast cancer? Beyer S, Jimenez R, Shapiro C, Jhiang S, Breast Cancer Res and Treat 2009 115 1 205 12 10.1007/s10549-008- 0059-5
25. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP, Biostat 2003 4 249 64 10.1093/biostatistics/ 4.2.249
26. Limma: linear models for microarray data. Smyth GK, Bioinformatics and Computational Biology Solutions using R and Bioconductor New York: Springer, Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W, 2005 397 420
27. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Smyth GK, Stat Appl Genet Mol Biol 2004 3 Article3
28. Control of the mean number of false discoveries, Bonferroni and stability of multiple testing. Gordon A, Glazko G, Qiu X, Yakovlev A, Annals of Applied Statistics 2007 1 179 90 10.1214/07-AOAS102
29. TM4 microarray software suite. Saeed AI, Bhagabati NK, Braisted JC, Liang W, Sharov V, Howe EA, Methods in Enzymology 2006 411 134 193 16939790
30. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Chen J, Bardes EE, Aronow BJ, Jegga AJ, Nucleic Acids Res 2009 37 305 W311 10.1093/nar/gkp427 19465376
31. Tissue iodine content and serum-mediated I125 uptake-blocking activity in breast cancer. Kilbane MT, Ajjan RA, Weetman AP, Dwyer R, McDermott EWM, O'Higgins NJ, Smyth PPA, J Clin Endocrinol Metab 2000 85 3 1245 1250 10.1210/jc.85.3.1245 10720070 (Pubitemid 32269380)
32. Gene expression regulation by retinoic acid: review. Balmer JE, Blomhoff R, J Lipid Res 2002 43 1773 1808 10.1194/jlr.R100015-JLR200 12401878 (Pubitemid 35315797)
33. An FAD-dependent pyridine nucleotide-disulfide oxidoreductase is involved in disulfide bond formation in FK228 anticancer depsipeptide. Wang C, Wesener SR, Zhang H, Cheng YQ, Chem Biol 2009 16 585 593 10.1016/j.chembiol.2009.05.005 19549597
34. Assessment of the sensitivity and specificity of oligonucleotide (50mer) microarrays. Kane MD, Jatkoe TA, Stumpf CR, Lu J, Thomas JD, Madore SJ, Nucleic Acids Res 2002 28 22 4552 4557
35. Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays. Yuen T, Wurmbach E, Pfeffer RL, Ebersole BJ, Sealfon SC, Nucleic Acids Res 2002 30 10 48 10.1093/nar/30.10.e48 12000853
36. Reliability and reproducibility issues in DNA microarray measurements. Draghici S, Khatri P, Eklund AC, Szallasi Z, Trends Genet 2006 22 2 101 109 10.1016/j.tig.2005.12.005 16380191 (Pubitemid 43152029)
37. Immunoanalysis indicates that the sodium iodide symporter is not overexpressed in intracellular compartments in thyroid and breast cancers. Peyrottes I, Navarro I, Ondo-Mendez A, Marcellin D, Bellanger L, Marsault R, Lindenthal S, Ettore F, Darcourt J, Pourcher T, Eur J Endocrinol 2009 160 215 225 19029227
38. A novel mechanism of sodium iodide symporter repression in differentiated thyroid cancer. Smith VE, Read ML, Turnell AS, Watkins RJ, Watkinson JC, Lewy GD, Fong JC, James SR, Eggo MC, Boelaert K, Franklyn JA, McCabe CJ, J Cell Sci 2009 122 3393 3340 10.1242/jcs.045427 19706688
39. Multifunctional proteins in tumorigenesis: aminoacyl-tRNA synthetases and translational components. Lee SW, Kang YS, Kim S, Curr Proteomics 2006 3 233 247 10.2174/157016406780655577 (Pubitemid 46740371)
40. Frequent loss of imprinting of PEG1/MEST in invasive breast cancer. Pedersen IS, Dervan PA, Broderick D, Harrison M, Miller N, Delany E, Cancer Res 1999 59 5449 51 10554015 (Pubitemid 29526454)
41. Regulation of Iodide Uptake and Sodium/Iodide Symporter Expression in the MCF-7 Human Breast Cancer Cell Line. Arturi F, Ferretti E, Presta I, Mattei T, Scipioni A, Scarpelli D, Bruno R, Lacroix L, Tosi E, Gulino A, Diego R, Filetti S, J Clin Endocrinol Metab 2005 90 2321 2326 10.1210/jc.2004-1562 15623812 (Pubitemid 40586280)
42. Basal-like breast cancer: a critical review. Rakha EA, Reis-Filho JS, Ellis IO, J Clin Oncol 2008 26 15 2568 2581 10.1200/JCO.2007.13.1748 18487574